Ingenia Therapeutics Inc. (KOSDAQ:950260)
25,350
-2,550 (-9.14%)
At close: Oct 8, 2026
| Market Cap | 1.25T |
| Revenue (ttm) | 7.42B |
| Net Income | -22.38B |
| EPS | -807.42 |
| Shares Out | 49.44M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 653,039 |
| Open | 27,500 |
| Previous Close | 27,900 |
| Day's Range | 24,550 - 27,850 |
| 52-Week Range | 9,900 - 29,950 |
| Beta | n/a |
| Analysts | n/a |
| Price Target | n/a |
| Est. Earnings | Nov 19, 2026 |